Loferer H - Search Results

1

Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumors.

van der Biessen DA, Burger H, de Bruijn P, Lamers CH, Naus N, Loferer H, Wiemer EA, Mathijssen RH, de Jonge MJ. van der Biessen DA, et al. Among authors: loferer h. Clin Cancer Res. 2014 Sep 15;20(18):4776-83. doi: 10.1158/1078-0432.CCR-14-0325. Epub 2014 Jul 14. Clin Cancer Res. 2014. PMID: 25024258 Clinical Trial.

2

Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.

Cirstea D, Hideshima T, Santo L, Eda H, Mishima Y, Nemani N, Hu Y, Mimura N, Cottini F, Gorgun G, Ohguchi H, Suzuki R, Loferer H, Munshi NC, Anderson KC, Raje N. Cirstea D, et al. Among authors: loferer h. Leukemia. 2013 Dec;27(12):2366-75. doi: 10.1038/leu.2013.194. Epub 2013 Jun 28. Leukemia. 2013. PMID: 23807770 Free PMC article.

3

Prediction of mechanisms of action of antibacterial compounds by gene expression profiling.

Hutter B, Schaab C, Albrecht S, Borgmann M, Brunner NA, Freiberg C, Ziegelbauer K, Rock CO, Ivanov I, Loferer H. Hutter B, et al. Among authors: loferer h. Antimicrob Agents Chemother. 2004 Aug;48(8):2838-44. doi: 10.1128/AAC.48.8.2838-2844.2004. Antimicrob Agents Chemother. 2004. PMID: 15273089 Free PMC article.

4

Panel of Bacillus subtilis reporter strains indicative of various modes of action.

Hutter B, Fischer C, Jacobi A, Schaab C, Loferer H. Hutter B, et al. Among authors: loferer h. Antimicrob Agents Chemother. 2004 Jul;48(7):2588-94. doi: 10.1128/AAC.48.7.2588-2594.2004. Antimicrob Agents Chemother. 2004. PMID: 15215113 Free PMC article.

5

Identification by RNA profiling and mutational analysis of the novel copper resistance determinants CrdA (HP1326), CrdB (HP1327), and CzcB (HP1328) in Helicobacter pylori.

Waidner B, Melchers K, Ivanov I, Loferer H, Bensch KW, Kist M, Bereswill S. Waidner B, et al. Among authors: loferer h. J Bacteriol. 2002 Dec;184(23):6700-8. doi: 10.1128/JB.184.23.6700-6708.2002. J Bacteriol. 2002. PMID: 12426358 Free PMC article.

6

EcfE, a new essential inner membrane protease: its role in the regulation of heat shock response in Escherichia coli.

Dartigalongue C, Loferer H, Raina S. Dartigalongue C, et al. Among authors: loferer h. EMBO J. 2001 Nov 1;20(21):5908-18. doi: 10.1093/emboj/20.21.5908. EMBO J. 2001. PMID: 11689431 Free PMC article.

7

DNA microarray technology and antimicrobial drug discovery.

Ivanov I, Schaab C, Planitzer S, Teichmann U, Machl A, Theml S, Meier-Ewert S, Seizinger B, Loferer H. Ivanov I, et al. Among authors: loferer h. Pharmacogenomics. 2000 May;1(2):169-78. doi: 10.1517/14622416.1.2.169. Pharmacogenomics. 2000. PMID: 11256588 Review.

8

Mining bacterial genomes for antimicrobial targets.

Loferer H. Loferer H. Mol Med Today. 2000 Dec;6(12):470-4. doi: 10.1016/s1357-4310(00)01815-3. Mol Med Today. 2000. PMID: 11099952 Review.

9

A genome-based approach for the identification of essential bacterial genes.

Arigoni F, Talabot F, Peitsch M, Edgerton MD, Meldrum E, Allet E, Fish R, Jamotte T, Curchod ML, Loferer H. Arigoni F, et al. Among authors: loferer h. Nat Biotechnol. 1998 Sep;16(9):851-6. doi: 10.1038/nbt0998-851. Nat Biotechnol. 1998. PMID: 9743119

10

Availability of the fibre subunit CsgA and the nucleator protein CsgB during assembly of fibronectin-binding curli is limited by the intracellular concentration of the novel lipoprotein CsgG.

Loferer H, Hammar M, Normark S. Loferer H, et al. Mol Microbiol. 1997 Oct;26(1):11-23. doi: 10.1046/j.1365-2958.1997.5231883.x. Mol Microbiol. 1997. PMID: 9383186 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters